Infectious laryngotracheitis is an important respiratory disease of chickens that is caused by an alphaherpesvirus [infectious laryngotracheitis virus (ILTV); Gallid herpesvirus 1]. As herpesvirus envelope glycoproteins are main targets of the humoral host immune response, they are of particular interest for development of vaccines, as well as of diagnostic tools. The conserved, Nglycosylated envelope protein gC has been identified as a major surface antigen of ILTV. To study the function of gC, we now isolated a gC-deleted ILTV recombinant as well as a gC rescuant after co-transfection of permissive chicken cells with virion DNA and transfer plasmids containing engineered subgenomic fragments. Like other alphaherpesvirus homologues, ILTV gC proved to be non-essential for replication. ILTV-DgC exhibited delayed penetration kinetics and slightly reduced plaque sizes in cultured chicken cells, whereas virus titres were not reduced significantly compared with wild-type or gC-rescued virus. In vivo studies revealed that ILTV-DgC is attenuated in chickens. However, infection with high doses of ILTV-DgC was still fatal for approximately 20 % of the animals, whereas wild-type or gC-rescued ILTV led to 50 % mortality. Interestingly, innate and specific immune responses against ILTV-DgC were not reduced but enhanced, and surviving chickens were protected completely against challenge infection. Furthermore, ILTV-DgC might serve as a basis for marker vaccines permitting differentiation between vaccinated and field-virus-infected animals, as gC-specific antibodies could be detected easily in sera of animals infected with wild-type ILTV.
INTRODUCTIONInfectious laryngotracheitis (ILT) is a worldwide-occurring and economically important respiratory disease of chickens caused by infectious laryngotracheitis virus (ILTV), also designated Gallid herpesvirus 1. After primary infection, an incubation period of 3-12 days is followed by an acute phase lasting 1-2 weeks. During this time, the virus replicates mainly in trachea, larynx and conjunctiva, leading to respiratory disorders such as gasping, coughing, expectoration of bloody mucus and, less frequently, conjunctivitis. ILTV infection further results in reduced weight gain and egg production, and induces mortality rates between 0 and 80 % depending on strain virulence (reviewed by Guy & Garcia, 2008). ILTV establishes lifelong latency in sensory neurons of surviving animals, and the virus can be reactivated by various stress factors with subsequent virus shedding (Williams et al., 1992). For prevention of ILT, conventionally attenuated live-virus vaccines are in use, which are suitable for mass application, but mostly possess significant residual virulence, which might increase after animal passage (Andreasen et al., 1990;Guy et al., 1991;Guy & Garcia, 2008;Kotiw et al., 1995). To overcome this problem, stably attenuated ILTV recombinants have been generated by targeted deletion of non-essential genes (reviewed by Fuchs et al., 2007).Gallid herpesvirus 1 (ILTV) has been classif...